Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by Accountprinceon Dec 20, 2022 9:49am
184 Views
Post# 35181872

RE:RE:RE:i-Dialco

RE:RE:RE:i-Dialco MM and Rev - both of you are posters I have a lot of respect for.  Do we have any facts relating to Infomed throwing in the rest of the world into the JV deal with Spectral?  Obviously that would change the perception of the deal.  But at this stage the only facts we have are through the news release of Dec 13 - that only mentions North America.  So how does the rest of the world factor in?  I would have thought if the deal included the rest of the world Spectral would have said so.

This just underscores the terrible lack of disclosure by Spectral on this matter.  I have looked on Sedar yet again today and there is no disclosure of the material agreement that must be disclosed between Spectral and Infomed.  If you believe the rest of the world is included in the deal can you clarify directly with management?  Thanks. 
<< Previous
Bullboard Posts
Next >>